COMPARISON OF THE INHIBITION OF THE MONOAMINE-OXIDASE BY 2 REVERSIBLE IMAO, MOCLOBEMIDE AND TOLOXATONE - STUDY OF THEIR EFFECT ON MEMORY AND VIGILANCE

被引:0
|
作者
BERLIN, I
ZIMMER, R
PAYAN, C
THIEDE, HM
ROBIN, L
PUECH, AJ
机构
[1] HOP LA PITIE SALPETRIERE,DEPT CLIN PHARMACOL,F-75651 PARIS 13,FRANCE
[2] KLINIKUM STEGLITZ,MED KLIN 1,BERLIN 45,GERMANY
[3] HOFFMANN LA ROCHE LTD,CH-4002 BASEL,SWITZERLAND
关键词
D O I
10.1016/0014-2999(90)93435-S
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:531 / 531
页数:1
相关论文
共 50 条
  • [1] COMPARISON OF THE MONOAMINE-OXIDASE INHIBITING PROPERTIES OF 2 REVERSIBLE AND SELECTIVE MONOAMINE OXIDASE-A INHIBITORS MOCLOBEMIDE AND TOLOXATONE, AND ASSESSMENT OF THEIR EFFECT ON PSYCHOMETRIC PERFORMANCE IN HEALTHY-SUBJECTS
    BERLIN, I
    ZIMMER, R
    THIEDE, HM
    PAYAN, C
    HERGUETA, T
    ROBIN, L
    PUECH, AJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (06) : 805 - 816
  • [2] MOCLOBEMIDE - A REVERSIBLE INHIBITOR OF MONOAMINE-OXIDASE TYPE-A
    BALDWIN, D
    RUDGE, S
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 1993, 49 (07): : 497 - &
  • [3] COMPARATIVE INVESTIGATION OF THE EFFECT OF MOCLOBEMIDE AND TOLOXATONE ON MONOAMINE-OXIDASE ACTIVITY AND PSYCHOMETRIC PERFORMANCE IN HEALTHY-SUBJECTS
    DINGEMANSE, J
    BERLIN, I
    PAYAN, C
    THIEDE, HM
    PUECH, AJ
    PSYCHOPHARMACOLOGY, 1992, 106 : S68 - S70
  • [4] A REVERSIBLE MONOAMINE-OXIDASE INHIBITOR, TOLOXATONE - STRUCTURAL AND ELECTRONIC-PROPERTIES
    MOUREAU, F
    WOUTERS, J
    VERCAUTEREN, DP
    COLLIN, S
    EVRARD, G
    DURANT, F
    DUCREY, F
    KOENIG, JJ
    JARREAU, FX
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1992, 27 (09) : 939 - 948
  • [5] EFFECT OF MOCLOBEMIDE, A NEW REVERSIBLE MONOAMINE-OXIDASE INHIBITOR, ON ABSORPTION AND PRESSOR EFFECT OF TYRAMINE
    KORN, A
    DAPRADA, M
    RAFFESBERG, W
    GASIC, S
    EICHLER, HG
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1988, 11 (01) : 17 - 23
  • [6] A REVERSIBLE MONOAMINE-OXIDASE INHIBITOR TOLOXATONE - COMPARISON OF ITS PHYSICOCHEMICAL PROPERTIES WITH THOSE OF OTHER INHIBITORS INCLUDING BROFAROMINE, HARMINE, R40519 AND MOCLOBEMIDE
    MOUREAU, F
    WOUTERS, J
    DEPAS, M
    VERCAUTEREN, DP
    DURANT, F
    DUCREY, F
    KOENIG, JJ
    JARREAU, FX
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1995, 30 (11) : 823 - 838
  • [7] TYRAMINE PRESSOR-RESPONSE WITH MOCLOBEMIDE - A REVERSIBLE MONOAMINE-OXIDASE INHIBITOR
    TILLER, JWG
    MAGUIRE, KP
    DAVIES, BM
    PSYCHIATRY RESEARCH, 1987, 22 (03) : 213 - 220
  • [8] MOCLOBEMIDE, A NEW REVERSIBLE MONOAMINE-OXIDASE INHIBITOR, AND TYRAMINE INTERACTION STUDIES
    SCHMIDBURGK, W
    GIESCHKE, R
    ALLEN, S
    AMREIN, R
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1988, 43 (05): : 903 - 917
  • [9] EFFECT OF MONOAMINE-OXIDASE INHIBITION ON EXPERIMENTAL CIRRHOSIS
    KIRCHNER, JP
    DAVIS, LM
    CASTELL, DO
    GASTROENTEROLOGY, 1973, 64 (01) : 185 - 185
  • [10] PHARMACOLOGICAL PROFILE OF MOCLOBEMIDE, A SHORT-ACTING AND REVERSIBLE INHIBITOR OF MONOAMINE-OXIDASE TYPE-A
    BURKARD, WP
    BONETTI, EP
    DAPRADA, M
    MARTIN, JR
    POLC, P
    SCHAFFNER, R
    SCHERSCHLICHT, R
    HEFTI, F
    MULLER, RKM
    WYSS, PC
    HAEFELY, W
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1989, 248 (01): : 391 - 399